Glioma D005910

Description

Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)   MeSH

Hierarchy View

Subtype Terms (8)

Astrocytoma
209 drugs (102 approved, 107 experimental)

Diffuse Intrinsic Pontine Glioma
87 drugs (39 approved, 48 experimental)

Ependymoma
122 drugs (73 approved, 49 experimental)

Ganglioglioma
6 drugs (4 approved, 2 experimental)

Gliosarcoma
163 drugs (83 approved, 80 experimental)

Medulloblastoma
149 drugs (84 approved, 65 experimental)

Oligodendroglioma
129 drugs (69 approved, 60 experimental)

Optic Nerve Glioma
11 drugs (9 approved, 2 experimental)


Phase 2 Indicated Drugs (190)

Phase 1 Indicated Drugs (141)


Organization Involved with Phase 2 Indications (245)

Fundación DISA, Canary Islands, Spain

Fundació Sant Joan de Déu

Gateway for Cancer Research

Genentech

GlaxoSmithKline

Government of Canada

Government of Taiwan

Grupo de Investigación Clínica en Oncología Radioterapia

Hackensack University Medical Center

Harvard University

Hebei University

Hebrew University

Hefei University

Henan Medical University

Hengrui Therapeutics, Inc.

Henry Ford Health System

Herbert Irving Comprehensive Cancer Center

Hospital Amaral Carvalho

Huazhong University of Science and Technology

Icahn School of Medicine at Mount Sinai

IKP Mannheim

Incyte

Indiana University

Innovative Therapies For Children with Cancer Consortium

Institut Gustave Roussy

Insys Therapeutics Inc

Istari Oncology, Inc.

Janssen Pharmaceutica NV

Jiao Tong University

Jinan University

Johns Hopkins University

John Wayne Cancer Institute

Julius-Maximilians University

Karyopharm Therapeutics Inc

Kentuckiana Cancer Institute

Keryx

Laminar Pharmaceuticals

Laval University

Leadiant Biosciences, Inc.

Legacy Health System

Light Sciences Oncology

Lipopharma Therapeutics SL

London Vaccination Clinic

Long Island Neuro-Oncology Associates

Mario Negri Institute

Marnie Rose Foundation

Martin Luther University

McGill University

Medical College of Wisconsin

Medical University Innsbruck

Medical University of South Carolina

Medicenna Therapeutics, Inc.

MediGene

MedImmune

Merck

Merck KGaA

Methodist Cancer Center, Houston, Texas

Methodist Healthcare

Michigan State University

Midatech Pharma

Millennium Pharmaceuticals

Millennix

The Pacific Pediatric Neuro-Oncology Consortium

The Pediatric Low Grade Astrocytoma Foundation

The Pew Charitable Trusts

The Spectrum Health Group

The University of Texas, Dallas

Thomas Jefferson University

TransMolecular

Treovir, LLC

Triphase Research and Development Corporation

Tsinghua University

Tufts University

TVAX Biomedical

Universidad Autonoma de Barcelona

Universidad Carlos III Madrid

University of Alabama, Birmingham

University of Alberta

University of Amsterdam

University of Barcelona

University of Bordeaux

University of Caen-Normandie

University of California, Davis

University of California, San Diego

University of Chicago

University of Cincinnati

University of Colorado

University of Copenhagen

University of Florida

University of Lille

University of London

University of Louisville

University of Lyon

University of Maryland

University of Melbourne

University of Michigan

University of Minnesota

University of Nebraska

University of North Carolina at Chapel Hill

University of Pennsylvania

University of Pittsburgh

University of Rochester

University of Southern California

University of Southern Denmark

University of South Florida

University of Texas, San Antonio

University of Toronto

University of Ulsan

University of Utah

University of Washington

University of Western Ontario

University of Wisconsin

University of Zurich

Vanderbilt University

Virginia Commonwealth University

Wake Forest University

Washington University in St. Louis

Yale University

Yankuang Group General Hospital

YM Biosciences

Zhejiang University

Organization Involved with Phase 1 Indications (88)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.